1. Abou-Auda HS (1998) Comparative phramacokinetics and pharmacodynamics of furosemide in Middle eastern and in Asian subjects. Int J Clin Pharmacol Ther 36:275–281
2. Adcock D, Kressin D, Martar RA (1997) Effects of 3.2 % vs. 3.8 % citrate concentration on routine coagulation testing. Am J Clin Pathol 107:105–110
3. Amantea MA, Narang PK (1988) Improved procedure for quantitation of omeprazole and metabolites using reversed-phase high-performance liquid chromatography. J Chromatogr 426:216–222
4. Arora P, Mukherjee B (2002) Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci 91:2076–2089
5. Bawazir SA, Gouda MW, El-Sayed YM, Al-Khamis KI, Al-Yamani MJ, Niazy EM, Al-Rashood KA (1998) Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers. Int J Clin Pharmacol Ther 36:270–274